News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wijkstrom Joakim
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/23/2023 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 3,724 shares
@ $5.84, valued at
$21.7k
|
|
| 03/06/2023 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 7,720 shares
@ $6.2335, valued at
$48.1k
Sold 4,113 shares
@ $6.32, valued at
$26k
|
|
| 02/21/2023 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 32,700 shares
@ $0
Granted 77,500 options to buy
@ $7.05, valued at
$546.4k
|
|
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2021 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 3,650 shares
@ $15.3944, valued at
$56.2k
|
|
| 03/03/2021 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 3,888 shares
@ $18.4488, valued at
$71.7k
|
|
| 02/26/2021 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 25,800 shares
@ $0
Granted 61,200 options to buy
@ $20.28, valued at
$1.2M
|
|
| 08/21/2020 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 3,710 shares
@ $11.0806, valued at
$41.1k
|
|
| 02/28/2020 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 70,000 options to buy
@ $11.32, valued at
$792.4k
|
|
| 08/21/2019 |
4
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 90,000 options to buy
@ $15.33, valued at
$1.4M
|
|
| 08/21/2019 |
3
| Wijkstrom Joakim (SVP, Chief Marketing Officer) has filed a Form 3 on Vanda Pharmaceuticals Inc. |
|
|